Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03392038 · ClinicalTrials.gov registry record · NA
Thick vs. Thin Acellular Dermal Matrix (ADM)
A NA study of Gingival Recession, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT03392038 is a NA study of Gingival Recession that has completed, run by University of Louisville. The registered enrollment target is 22 participants, below the 31-participant average among 10 other Gingival Recession trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03392038, a NA study of Gingival Recession, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
To study and compare a thick vs thin acellular dermal matrix for root coverage using the coronally positioned tunnel technique.
Conditions Studied
Interventions
- PROCEDURE Thin ADM
- PROCEDURE Thick ADM
Study Locations (1)
Kentucky
- Graduate Periodontics, UofL School of Dentistry - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2017-11-30 |
| Est. Completion | 2018-08-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03392038
The ClinicalTrials.gov registry entry for NCT03392038 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 31-participant average among 10 other Gingival Recession trials with a reported enrollment target (29% lower). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gingival Recession appearing as the primary indexed condition, and to 2 interventions - of which Thin ADM is the first listed.
NCT03392038 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT03392038 about?
NCT03392038 is a clinical study titled "Thick vs. Thin Acellular Dermal Matrix (ADM)". To study and compare a thick vs thin acellular dermal matrix for root coverage using the coronally positioned tunnel technique.
What is the current status of trial NCT03392038?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2017-11-30. Estimated completion is 2018-08-21.
What conditions does trial NCT03392038 study?
This clinical trial studies the following conditions: Gingival Recession.
What interventions are being tested in trial NCT03392038?
The interventions under investigation include: Thin ADM (PROCEDURE), Thick ADM (PROCEDURE).
Who is sponsoring clinical trial NCT03392038?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03392038 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gingival Recession
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gain of Keratinized Mucosa Around Teeth and Dental Implants Using a Combination of Strip Gingival Graft and Acellular Dermal Matrix
RECRUITING · NA
-
Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
RECRUITING · NA
-
Changes of Soft Tissue Grafting: A Randomized Study
RECRUITING · NA
-
A Comparison of Side Access Mucosal Releasing Incision (SAMRI) and Sulcular Tunnel Access to Treat Gingival Recession.
ACTIVE NOT RECRUITING · NA
-
Evaluation of Geistlich Fibro-Gide® + CAF in Comparison to CTG + CAF for the Treatment of Recession Defects at 6 Months
COMPLETED · NA
-
Treatment of Gingival Recession Defects Using Platelet-Rich Fibrin With an Allogenic Dermal Matrix
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.